An Initiative Supported by The Nashville Area Chamber of Commerce and Global Health Connector. The Global Health Innovators Summit III GHIS III) will take place on September 16, 2026, at Cannery Hall in Nashville, preceded by a dedicated startup workshop on September 15.
The event aims to unite over 300 healthcare leaders and features panels centered around "Culture as Medicine," alongside the high-stakes Global Health Connector International Pitch Event. It serves as the definitive market entry point for international healthtech companies looking to scale into the U.S. healthcare ecosystem.
If you are interested in sponsorship, there is a way to get involved! For more information, please contact Estelle@globalhealthconnector.com and review the official Sponsor Pack.
We have a special discount code for our Global Health Connector community: GHISFRIEND for a 20% discount.
Presented by Global Health Innovators, Global Health Connector and in collaboration with the Nashville Area Chamber of Commerce, the Global Health Innovation Summit III (GHIS III) is Nashville’s premier gathering for global health leaders.
Taking place on September 16, 2026, at Cannery Hall, Nashville, this full-day summit serves as the definitive U.S. market entry point for international healthcare and healthtech companies looking to leverage Nashville's massive $100B+ healthcare ecosystem.
We have a special discount code for our Global Health Connector community: GHISFRIEND for a 20% discount.
How do music, art, sport, and culture shape the health of populations - and what does that mean for innovators?
This year´s summit will explore how cultural pillars shape population health outcomes and equity. Programming will be centered around four key tracks:
Date: September 15, 2026 Location: Nashville Entrepreneur Center
Kickstart your summit experience with a dedicated, hands-on masterclass designed for international founders entering the U.S. healthcare landscape. Led by our US Ambassador, Nicole Althaus, this targeted session breaks down practical strategies for scaling, navigating regional hubs, and establishing a successful operational footprint in America.
Learn more about the session structure and curriculum here.
The day will feature world-class speakers, curated panel discussions, and tight, high-signal presentations:
The GHIS III International Pitch Event will provide a high-stakes, global stage for high-growth healthcare innovation. The competition will serve as a direct bridge connecting international founders with elite capital and ecosystem leaders.
You can apply to GHIS III International Pitch Event here (Deadline 31st July)
If you are interested in sponsorship, there is a way to get involved! For more information, please contact heather@globalhealthconnector.com and review the official Sponsor Pack.
A landmark 2025 federal law created a $50 billion program to transform rural healthcare access, quality, and sustainability, with every state now holding an active award. This panel looks at how that money is actually being deployed and where the real openings are for startups, health systems, and technology providers. Expect a candid conversation about the distance between a funding announcement and patient impact.
Some of the most active investors in digital health discuss what's driving conviction in 2026 and how they think about the regulatory and reimbursement gauntlet that separates a great product from a scalable business. The conversation moves past standard pitch advice to what founders consistently underestimate when raising — including how international founders should approach entering the U.S. market.
Coverage, payment, data access, and the rules governing AI are all set at the federal level, where a single line in a rule can decide whether a promising product becomes a viable business. This panel brings federal voices together to explain where government is encouraging AI adoption versus where it intends to regulate, and what a model announcement signals about commercial timing. Built for practical intelligence rather than policy recitation.
Generative AI has produced new entrants faster than any buyer can reasonably evaluate, and the hard problem is no longer finding solutions — it's separating signal from noise. This panel convenes independent experts with no product to sell and no position to defend, who spend their days tracking capital flows, adoption behavior, and the evidence beneath the claims. They'll address which categories are genuinely accelerating and what separates a solution that survives procurement from one that stalls in pilot.
